Company Analysis
IndustriesBiological Products, (No Diagnostic Substances)

Biological Products, (No Diagnostic Substances)

Open in the Screener
Companies
159
Median grade
5.00
Highest
KRYS 7.56
Lowest
SNTI 2.59

A grade ranks a company against its own industry, from its filings. It is not a view on the share price. 159 of 5,495 companies on file are in this industry.

Company, by gradeGrade◀ Past● Present▶ FutureArcFiled
1KRYSKrystal Biotech, Inc.7.567.19.06.1Falling9 of 9
2EXELExelixis, Inc.7.518.68.55.1Falling9 of 9
3NBIXNeurocrine Biosciences, Inc.7.378.47.85.8Falling9 of 9
4VCELVericel Corporation7.197.48.15.7Falling9 of 9
5HALOHalozyme Therapeutics, Inc.6.847.97.35.2Falling9 of 9
6AMGNAmgen Inc.6.797.17.75.2Falling9 of 9
7CGENCompugen Ltd.6.786.17.26.9Rising8 of 9
8GILDGilead Sciences, Inc.6.767.37.55.3Falling9 of 9
9MAZEMaze Therapeutics, Inc.6.706.17.95.7Falling3 of 9
10IMCRImmunocore Holdings plc6.667.36.66.1Falling8 of 9
11ADMAADMA Biologics Inc6.556.87.84.7Falling9 of 9
12FDMT4D Molecular Therapeutics, Inc.6.445.87.16.2Rising8 of 9
13BEAMBeam Therapeutics Inc.6.386.96.65.5Falling8 of 9
14QGENQiagen N.V.6.357.56.74.7Falling8 of 9
15TECHBio-Techne Corp6.357.27.34.2Falling9 of 9
16ARGXargenx SE6.305.56.37.1Rising7 of 9
17TARSTarsus Pharmaceuticals, Inc.6.295.67.06.0Rising8 of 9
18GLUEMonte Rosa Therapeutics, Inc.6.206.56.26.0Falling7 of 9
19TWSTTwist Bioscience Corporation6.207.27.64.4Falling8 of 9
20MGTXMeiraGTx Holdings plc6.187.15.95.7Falling7 of 9
21TECXTectonic Therapeutic, Inc.6.176.35.66.6Rising2 of 9
22ADPTAdaptive Biotechnologies Corporation6.156.37.14.8Falling8 of 9
23ALVOAlvotech6.157.36.05.1Falling7 of 9
24BCRXBioCryst Pharmaceuticals, Inc.6.086.35.66.4Rising9 of 9
25KODKodiak Sciences Inc6.056.26.35.8Falling3 of 9
26IOVAIovance Biotherapeutics, Inc.6.047.06.15.0Falling7 of 9
27AVXLAnavex Life Sciences Corp.5.945.15.86.6Rising3 of 9
28CSBRChampions Oncology, Inc.5.936.96.64.1Falling8 of 9
29BIIBBiogen Inc.5.926.46.74.4Falling9 of 9
30BDTXBlack Diamond Therapeutics, Inc.5.905.77.15.0Falling5 of 9
31BNTXBioNTech SE5.896.85.85.0Falling8 of 9
32IMVTImmunovant, Inc.5.755.55.06.5Rising3 of 9
33ODTXOdyssey Therapeutics, Inc.5.755.96.55.0Falling1 of 9
34SCTXScribe Therapeutics Inc.5.755.96.55.0Falling1 of 9
35MRNAModerna, Inc.5.707.36.03.6Falling8 of 9
36IPSCCentury Therapeutics, Inc.5.674.66.26.1Rising8 of 9
37DNLIDenali Therapeutics Inc.5.655.77.34.1Falling5 of 9
38IMTXImmatics N.V.5.655.45.65.8Rising2 of 9
39FENCFennec Pharmaceuticals Inc.5.646.56.53.7Falling8 of 9
40RGNXRegenxbio Inc.5.647.05.44.7Falling8 of 9
41CABACabaletta Bio, Inc.5.625.95.55.6Falling3 of 9
42CLLSCellectis S.A.5.624.95.46.7Rising7 of 9
43COAGHemab Therapeutics Holdings, Inc.5.615.96.25.0Falling1 of 9
44EIKNEikon Therapeutics, Inc.5.615.96.25.0Falling1 of 9
45CGONCG Oncology, Inc.5.595.45.75.6Rising6 of 9
46LENZLENZ Therapeutics, Inc.5.576.55.84.8Falling4 of 9
47LCTXLineage Cell Therapeutics, Inc.5.566.15.55.3Falling8 of 9
48RLAYRelay Therapeutics, Inc.5.544.76.65.2Rising8 of 9
49NVAXNovavax, Inc.5.525.35.75.6Rising8 of 9
50MESOMesoblast Limited5.474.55.16.4Rising7 of 9
51IBRXImmunityBio, Inc.5.455.25.16.2Rising8 of 9
52PLXProtalix BioTherapeutics, Inc.5.424.97.03.8Falling9 of 9
53RGENRepligen Corporation5.426.36.44.1Falling9 of 9
54ABOSAcumen Pharmaceuticals, Inc.5.416.05.54.9Falling3 of 9
55VYGRVoyager Therapeutics, Inc.5.386.15.64.3Falling8 of 9
56GNTAGenenta Science S.p.A.5.366.75.64.3Falling2 of 9
57CRDLCardiol Therapeutics Inc.5.346.13.66.4Rising2 of 9
58MOLNMolecular Partners AG5.325.75.45.0Falling4 of 9
59LONALeonaBio, Inc.5.295.44.46.0Rising3 of 9
60PROKProKidney Corp.5.285.63.66.5Rising6 of 9
61CGEMCullinan Therapeutics, Inc.5.275.26.14.6Falling5 of 9
62INKTMiNK Therapeutics, Inc.5.275.23.96.5Rising3 of 9
63EXOZeXoZymes Inc.5.265.74.55.6Falling3 of 9
64IVVDInvivyd, Inc.5.235.35.35.1Falling7 of 9
65PHGEBiomX Inc.5.214.25.06.0Rising1 of 9
66AGMBAgomAb Therapeutics NV5.195.95.05.0Falling1 of 9
67SLBTSL Science Holding Limited5.195.95.05.0Falling1 of 9
68CADLCandel Therapeutics, Inc.5.184.83.56.9Rising6 of 9
69VIRVir Biotechnology, Inc.5.167.14.34.5Falling8 of 9
70PASGPassage Bio, Inc.5.145.44.06.0Rising3 of 9
71CCCCC4 Therapeutics, Inc.5.115.45.14.8Falling8 of 9
72CGTXCognition Therapeutics, Inc.5.113.94.96.1Rising3 of 9
73KYMRKymera Therapeutics, Inc.5.086.25.33.6Falling8 of 9
74CRSPCRISPR Therapeutics AG5.066.06.23.5Falling8 of 9
75EVAXEvaxion A/S5.065.34.35.6Rising7 of 9
76INMBINmune Bio Inc.5.054.83.07.0Rising8 of 9
77TSHATaysha Gene Therapies, Inc.5.054.35.65.0Rising8 of 9
78REPLReplimune Group, Inc.5.035.64.35.3Falling2 of 9
79PCVXVaxcyte, Inc.5.005.36.23.7Falling3 of 9
80TARAProtara Therapeutics, Inc.5.004.05.94.9Rising3 of 9
81INABIN8bio, Inc.4.973.44.66.3Rising3 of 9
82SANASana Biotechnology, Inc.4.966.24.64.5Falling3 of 9
83RVMDRevolution Medicines, Inc.4.903.85.45.1Rising5 of 9
84TILInstil Bio, Inc.4.905.95.53.7Falling3 of 9
85BCABBioAtla, Inc.4.874.84.05.7Rising4 of 9
86TNYATenaya Therapeutics, Inc.4.853.74.45.9Rising3 of 9
87AURAAura Biosciences, Inc.4.845.34.15.2Falling3 of 9
88PMCBPharmaCyte Biotech, Inc.4.847.04.63.7Falling5 of 9
89STROSutro Biopharma, Inc.4.834.24.75.7Rising8 of 9
90CHRSCoherus Oncology, Inc.4.823.55.65.0Rising8 of 9
91DBVTDBV Technologies S.A.4.803.74.26.0Rising8 of 9
92PALIPalisade Bio, Inc.4.801.44.47.3Rising4 of 9
93CRBUCaribou Biosciences, Inc.4.765.84.74.2Falling8 of 9
94EDITEditas Medicine, Inc.4.765.24.15.2Level8 of 9
95SRRKScholar Rock Holding Corporation4.763.84.35.8Rising5 of 9
96ZURAZura Bio Limited4.732.93.96.6Rising3 of 9
97DTILPrecision BioSciences, Inc.4.704.84.64.7Falling8 of 9
98CMPXCompass Therapeutics, Inc.4.694.05.54.4Rising5 of 9
99OKYOOKYO Pharma Limited4.685.33.45.4Rising1 of 9
100ELUTElutia Inc.4.673.25.15.2Rising8 of 9
101ARMPArmata Pharmaceuticals, Inc.4.666.04.63.9Falling3 of 9
102TCRXTScan Therapeutics, Inc.4.663.93.46.3Rising8 of 9
103NMRANeumora Therapeutics, Inc.4.653.44.15.9Rising3 of 9
104RXRXRecursion Pharmaceuticals, Inc.4.645.93.94.4Falling8 of 9
105INTSIntensity Therapeutics, Inc.4.613.33.66.3Rising2 of 9
106KYTXKyverna Therapeutics, Inc.4.614.04.25.4Rising3 of 9
107VALNValneva SE4.606.24.33.4Falling7 of 9
108ARTVArtiva Biotherapeutics, Inc.4.582.54.65.8Rising4 of 9
109MGXMetagenomi Therapeutics, Inc.4.584.44.94.4Level7 of 9
110LXEOLexeo Therapeutics, Inc.4.564.24.54.9Rising3 of 9
111INBXInhibrx Biosciences, Inc.4.545.24.24.4Falling7 of 9
112CELZCreative Medical Technology Holdings, Inc.4.525.75.03.4Falling7 of 9
113DNAGinkgo Bioworks Holdings, Inc.4.524.15.14.2Rising8 of 9
114SLDBSolid Biosciences Inc.4.513.05.15.0Rising6 of 9
115AGENAgenus Inc.4.463.55.24.5Rising8 of 9
116CRDFCardiff Oncology, Inc.4.434.93.74.8Falling8 of 9
117APGEApogee Therapeutics, Inc.4.413.75.34.1Rising1 of 9
118OCGNOcugen, Inc.4.394.44.34.4Level7 of 9
119KLRSKalaris Therapeutics, Inc.4.343.62.86.2Rising3 of 9
120IKTInhibikase Therapeutics, Inc.4.322.44.15.7Rising5 of 9
121AUTLAutolus Therapeutics plc4.293.15.34.1Rising4 of 9
122ENGNenGene Therapeutics Inc.4.294.13.84.8Rising3 of 9
123IPHAInnate Pharma S.A.4.265.94.03.5Falling7 of 9
124SLXNSilexion Therapeutics Corp4.262.32.76.8Rising6 of 9
125DYAIDyadic International, Inc.4.235.24.63.3Falling8 of 9
126GRMLGreenland Mines Ltd.4.232.93.26.0Rising2 of 9
127ACOGAlpha Cognition Inc.4.203.83.35.2Rising4 of 9
128PLURPluri Inc.4.173.63.75.0Rising8 of 9
129CVMCel-Sci Corporation4.162.44.35.1Rising6 of 9
130XFORX4 Pharmaceuticals, Inc.4.151.83.46.3Rising7 of 9
131SCLXScilex Holding Company4.144.53.44.8Rising8 of 9
132PRMEPrime Medicine, Inc.4.113.73.05.4Rising7 of 9
133CRISCuris, Inc.4.103.44.14.5Rising8 of 9
134FATEFate Therapeutics, Inc.4.105.14.53.1Falling8 of 9
135BCDABioCardia, Inc.4.072.14.64.9Rising5 of 9
136JSPRJasper Therapeutics, Inc.4.062.92.56.2Rising3 of 9
137LIMNLiminatus Pharma, Inc.4.063.53.45.0Rising2 of 9
138ESLAEstrella Immunopharma, Inc.4.032.73.45.4Rising2 of 9
139VORVor Biopharma Inc.4.033.51.76.4Rising2 of 9
140CLDICalidi Biotherapeutics, Inc.3.963.22.45.8Rising3 of 9
141SABSSAB Biotherapeutics, Inc.3.942.14.64.5Rising5 of 9
142ATRAAtara Biotherapeutics, Inc.3.933.93.34.7Rising8 of 9
143ALGSAligos Therapeutics, Inc.3.912.64.14.6Rising8 of 9
144HUMAHumacyte, Inc.3.914.23.24.3Rising5 of 9
145SCNIScinai Immunotherapeutics Ltd.3.913.53.84.3Rising4 of 9
146ENTXEntera Bio Ltd.3.863.43.54.5Rising8 of 9
147ALECAlector, Inc.3.755.94.02.2Falling8 of 9
148QNCXQuince Therapeutics, Inc.3.734.63.03.8Falling3 of 9
149ALLOAllogene Therapeutics, Inc.3.713.14.93.1Level5 of 9
150ATYRaTyr Pharma, Inc.3.682.44.83.5Rising8 of 9
151IMAImageneBio, Inc.3.635.02.63.7Falling7 of 9
152OTLKOutlook Therapeutics, Inc.3.623.52.44.8Rising5 of 9
153ELOXEloxx Pharmaceuticals, Inc.3.462.31.65.8Rising5 of 9
154PTHSPelthos Therapeutics Inc.3.442.52.94.5Rising4 of 9
155TVGNTevogen Bio Holdings Inc.3.322.63.14.0Rising2 of 9
156AIMAIM ImmunoTech Inc.3.312.63.73.4Rising7 of 9
157VIVSVivoSim Labs, Inc.3.281.72.74.8Rising8 of 9
158SRZNSurrozen, Inc.2.721.92.53.4Rising7 of 9
159SNTISenti Biosciences Holdings, Inc.2.591.22.13.9Rising7 of 9
Next deadlinesfrom the SEC's rules
  • Nov 14BCAB10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14CLDI10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14CRIS10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14DYAI10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14ELOX10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14ESLA10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14EXOZ10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14GRML10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14INBX10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30
  • Nov 14IVVD10-Q due under the SEC's rules, the quarterly report for the period ended 2026-09-30

A deadline is the rule's date for the filer's category, never a prediction.

SI Assistanton Biological Products, (No Diagnostic Substances) · research, not advice